Higher plasma levels of TFPI, which have been reported in CHD patients [9], may reflect a compensatory mechanism due to activation of the TF coagulation pathway, but may also reflect endothelial dysfunction in the atherosclerotic process. The gene discussed is TF; the disease is coronary artery disorder.